株式会社極東書店トップ ＞ 商品一覧 ＞ Pharmaceutical Patents under the SPC Regulation.
商品詳細
Pharmaceutical Patents under the SPC Regulation.
・ISBN 978-1-80392-737-4 hard GB£ 150.00
￥47,520.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
お気に入り
★★★
| 著者・編者 | Callesen Klinge, Ulla, |
|---|---|
| シリーズ | Elgar Intellectual Property Law and Practice |
| 出版社 | (E. Elgar, UK) |
| 出版年月 | 2022.10 |
| ページ数 | 296 pp. |
| 言語 | ENG |
| ニュース番号 | ＜680-522 680-702＞ |
解説
Written by an experienced European Patent Attorney and scholar, this book sets out in detail the framework for protection of pharmaceutical innovation under the SPC Regulation. With a focus on both biotechnological innovation and secondary innovation, and through extensive reference to the case law, Ulla Klinge surveys the court's evolving interpretation of legal and technical eligibility for this extended term of protection. This book provides clear and pragmatic tools to reflect and guide future practice, while offering key explanations and insights as to why and how technological developments challenge the legal SPC framework.
Key Features:
- Broad, practitioner-oriented approach offers a useful source of reference alongside practical guidance
- Analysis of SPC case law in light of developments in pharmaceutical technology, including both legal and technical aspects of the cases
- Examination of the lack of clarity in interpretation of the legislation and how this might be exploited by stakeholders
Pharmaceutical Patents under the SPC Regulation is an indispensable practical resource for patent law practitioners, including patent attorneys and attorneys-at-law in the SPC field. It will also prove useful to national patent authorities, legislators, and academics working at the intersection between pharmaceuticals and legal research.